Info

Phyton Biotech is the pioneer of commercial plant cell fermentation for production of small molecules and is developing this technology to encompass recombinant proteins. Therapies of the future , demanding human proteins with complicated folding patterns and complex glycosylation , are in development and will be produced in our dedicated fermentation facilities, located in Princeton, NJ and Ahrensburg, Germany. Phyton Biotech's specialty is production of sophisticated human therapeutic agents through plant cell fermentation, which makes us the undeniable choice for your protein of interest. We provide rapid scale-up resulting in the shortest possible timeline for development of your product. Phyton Biotech is also known for manufacturing paclitaxel for Bristol-Myers Squibb's TAXOL® in our large-scale cGMP fermentation facility in Germany.